Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nakornthon Hospital PCLBKK:NKT 16 EV-to-EBITDA is 6.33 as of Sep. 15, 2026, which is 48% above its 10-year median of 4.27. GuruFocus rates BKK:NKT with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 520 Healthcare Providers & Services companies, Nakornthon Hospital PCL ranks better than 75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nakornthon Hospital PCL's enterprise value is ฿2,150 Mil.
Nakornthon Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ฿340 Mil. Therefore, Nakornthon Hospital PCL's EV-to-EBITDA for today is 6.33.
The historical rank and industry rank for Nakornthon Hospital PCL's EV-to-EBITDA or its related term are showing as below:
BKK:NKT'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.35 Med: 4.27 Max: 8.25
Current: 6.33
During the past 4 years, the highest EV-to-EBITDA of Nakornthon Hospital PCL was 8.25. The lowest was 3.35. And the median was 4.27.
BKK:NKT's EV-to-EBITDA is ranked better than 75% of 520
companies
in the Healthcare Providers & Services industry
Industry Median: 10.33
vs BKK:NKT: 6.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nakornthon Hospital PCL's PE Ratio (TTM) for today is calculated as:
Nakornthon Hospital PCL's share price for today is ฿3.72.
Nakornthon Hospital PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.215.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Nakornthon Hospital PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nakornthon Hospital PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nakornthon Hospital PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nakornthon Hospital PCL's EV-to-EBITDA falls into.
Nakornthon Hospital PCL's current Enterprise Value is ฿2,150 Mil.
Nakornthon Hospital PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿340 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nakornthon Hospital PCL (BKK:NKT) has a EV-to-EBITDA of 6.33 as of Sep. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nakornthon Hospital PCL. This is 48% above median its historical median of 4.27. Over the past decade, Nakornthon Hospital PCL's EV-to-EBITDA has ranged from 3.35 to 8.25. According to the industry distribution chart, Nakornthon Hospital PCL ranks #130 out of 520 companies in the Healthcare Providers & Services industry, placing it in the top 25%.
Is Nakornthon Hospital PCL's EV-to-EBITDA too high?
Nakornthon Hospital PCL's current EV-to-EBITDA of 6.33 is 48% above median its 10-year median of 4.27. Over the past 10 years, this metric has ranged from a low of 3.35 to a high of 8.25. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.33. Nakornthon Hospital PCL's value of 6.33 is 38.7% below this industry median. Based on the distribution chart, Nakornthon Hospital PCL ranks #130 out of 520 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nakornthon Hospital PCL has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Nakornthon Hospital PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nakornthon Hospital PCL ranks #130 out of 520 companies for EV-to-EBITDA. This places Nakornthon Hospital PCL in the top 25% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.33. Nakornthon Hospital PCL's value of 6.33 is 38.7% below this benchmark. Historically, Nakornthon Hospital PCL's own EV-to-EBITDA has ranged from 3.35 to 8.25 over the past decade. While the company's 10-year median is 4.27 vs. the industry median of 10.33, Nakornthon Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.33, based on 520 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nakornthon Hospital PCL's current EV-to-EBITDA of 6.33 is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nakornthon Hospital PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakornthon Hospital PCL's current EV-to-EBITDA is 6.33, which is 48% above median its own 10-year median of 4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakornthon Hospital PCL stock overvalued right now?
Nakornthon Hospital PCL (BKK:NKT) has a current EV-to-EBITDA of 6.33. The current EV-to-EBITDA is 6.33, which is 48% above median its 10-year median of 4.27 and 38.7% below the Healthcare Providers & Services industry median of 10.33. Nakornthon Hospital PCL's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Nakornthon Hospital PCL (BKK:NKT), the current EV-to-EBITDA is 6.33 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nakornthon Hospital PCL is engaged in the healthcare industry. It is principally engaged in the hospital business offering specialty centers such as Orthopedics Center, Neurology Center, Gastrointestinal and Liver Center, and Nakornthon Fertility Center by Superior A.R.T. The company has two reportable segments which are hospital operations and other businesses that support hospital business including distribution of health and cosmetic products, facility management, and restaurant. A majority of its revenue is generated from the hospital business. Its operations are carried on in the geographical area of Thailand.
16GF Score
Get the complete analysis for BKK:NKT
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NKT has been successfully added to your 
